ChronoScale vs Inlif
CHRN and INLF side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CHRN | INLF |
|---|---|---|
| Size and price | ||
| Share price | $9.95 | $0.515 |
| Change, 1 year | 82.6% | −100.0% |
| Change, 5 years | −80.5% | – |
| Beta (5Y) | 1.27 | 2.82 |
| Employees | – | 16 |
| StockData Score | ||
| Total score | – | 4 |
| Valuation score | – | 0 |
| Growth score | – | 2 |
| Performance score | – | 0 |
| Health score | – | 2 |
| Dividend score | – | 0 |
| Growth | ||
| Revenue growth (TTM) | – | 16.5% |
| Net income growth (TTM) | – | −439% |
| EPS growth (TTM) | – | −354% |
| Profitability | ||
| Gross margin | – | 23.3% |
| Operating margin | – | −31.6% |
| Net margin | – | −29.6% |
| FCF margin | – | −11.3% |
| Return on equity | – | −12.5% |
| Return on invested capital | – | −18.9% |
| Financial health | ||
| Debt / equity | – | 0.10 |
| Interest coverage | – | −37.0× |
| Current ratio | – | 5.65 |
| Piotroski F-score | – | 4 |
| Ownership | ||
| Held by institutions | 0.73% | 0.43% |
| Held by insiders | 100% | 99.1% |
| Insider net buying, 12 months | $1.2M (better) | $27.3K |
| Short interest, % of float | – | 2617% |
Go deeper
- CHRN stock overview
- CHRN income statement
- CHRN valuation and score
- INLF stock overview
- INLF income statement
- INLF valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.